Home › Compare › NXEN vs MO

NXEN vs MO: Dividend Comparison 2026

NXEN yields 2000000.00% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXEN wins by $4.879226400974806e+39M in total portfolio value
10 years
NXEN
NXEN
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full NXEN calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — NXEN vs MO

📍 NXEN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXENMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXEN + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NXEN pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXEN
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, NXEN beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXEN + MO for your $10,000?

NXEN: 50%MO: 50%
100% MO50/50100% NXEN
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

NXEN
No analyst data
Altman Z
-2078.6
Piotroski
1/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXEN buys
0
MO buys
0
No recent congressional trades found for NXEN or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXENMO
Forward yield2000000.00% ✓6.36%
Annual dividend / share$2.00$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6% ✓
Portfolio after 10y$4.879226400974806e+39M$80.1K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$30,159.17
Total dividends collected$4.879195005460081e+39M$74.5K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NXEN vs MO ($10,000, DRIP)

YearNXEN PortfolioNXEN Income/yrMO PortfolioMO Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,570$780.30+$200.00M → NXEN
2$3,738,731,768,458$3,738,517,757,009.35$11,381$1,032.90+$3738731.76M → NXEN
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,535$1,392.73+$65315062866.92M → NXEN
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$14,193$1,920.91+$1066400830062625.00M → NXEN
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$16,618$2,723.68+$16272182796453826560.00M → NXEN
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$20,263$3,993.80+$2.3205424011366188e+23M → NXEN
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$25,936$6,098.36+$3.0927990661046884e+27M → NXEN
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$35,166$9,775.01+$3.8524105697352695e+31M → NXEN
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$51,026$16,597.78+$4.484688260147987e+35M → NXEN
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$80,113$30,159.17+$4.879226400974806e+39M → NXEN

NXEN vs MO: Complete Analysis 2026

NXEN — Stock

Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Full NXEN Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this NXEN vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXEN vs SCHDNXEN vs JEPINXEN vs ONXEN vs KONXEN vs MAINNXEN vs PMNXEN vs BTINXEN vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.